The Effects of Social Contact on Cocaine Intake Under Extended-access Conditions in Male Rats
Overview
Affiliations
Social learning theories of drug use propose that drug use is influenced by the behavior of peers. We previously reported that cocaine self-administration under limited-access conditions can be either facilitated or inhibited by social contact, depending on the behavior of a peer. The purpose of this study was to determine whether social contact influences cocaine self-administration under conditions that are more representative of problematic patterns of drug use. Male rats were assigned to either isolated or pair-housed conditions in which a social partner either had access to cocaine or did not have access to cocaine. Pair-housed rats were tested in custom-built operant conditioning chambers that allowed both rats to be tested simultaneously in the same chamber. In Experiment 1, rats were tested for 14 consecutive days during daily 6-hr test sessions. In Experiment 2, different doses of cocaine were tested in 23-hr test sessions conducted every 3 days. All groups of rats escalated their cocaine intake in Experiment 1; however, pair-housed rats with a partner without access to cocaine had lower levels of intake throughout the 14 days of testing. In Experiment 2, pair-housed rats with a partner without access to cocaine had lower levels of cocaine intake than did rats with a partner with access to cocaine, and this effect was observed at all doses of cocaine tested. These data indicate that the behavior of a social partner (i.e., whether or not that partner is also self-administering cocaine) influences cocaine self-administration under conditions that model problematic patterns of drug use. (PsycINFO Database Record
Smith M, Armas S, Camp J, Carlson H Psychopharmacology (Berl). 2024; 242(1):71-83.
PMID: 38992255 PMC: 11742770. DOI: 10.1007/s00213-024-06648-z.
Role of social context in addiction etiology and recovery.
Strickland J, Acuff S Pharmacol Biochem Behav. 2023; 229:173603.
PMID: 37487953 PMC: 10528354. DOI: 10.1016/j.pbb.2023.173603.
Smith M, Cha H, Sharp J, Strickland J Pharmacol Biochem Behav. 2022; 222:173511.
PMID: 36572113 PMC: 9845135. DOI: 10.1016/j.pbb.2022.173511.
Venniro M, Marino R, Chow J, Caprioli D, Epstein D, Ramsey L J Neurosci. 2022; 42(50):9298-9314.
PMID: 36517252 PMC: 9794371. DOI: 10.1523/JNEUROSCI.0931-22.2022.
Smith M, Schmidt K, Sharp J, Pearson T, Davis A, Gibson A Eur J Pharmacol. 2021; 913:174646.
PMID: 34800468 PMC: 8675402. DOI: 10.1016/j.ejphar.2021.174646.